Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date
Carmen Criscitiello, Giulia Viale, Giuseppe Curigliano, Aron Goldhirsch European Institute of Oncology, Milano, Italy Abstract: Alteration of the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin signaling pathway is key for the growth and survival of...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-01-01
|
| Series: | Breast Cancer : Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/profile-of-buparlisib-and-its-potential-in-the-treatment-of-breast-can-peer-reviewed-article-BCTT |